Tactile Systems Technology (TCMD)
(Delayed Data from NSDQ)
$13.20 USD
-0.19 (-1.42%)
Updated Sep 6, 2024 04:00 PM ET
After-Market: $13.21 +0.01 (0.08%) 7:00 PM ET
3-Hold of 5 3
A Value A Growth D Momentum A VGM
Price, Consensus and EPS Surprise
TCMD 13.20 -0.19(-1.42%)
Will TCMD be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for TCMD based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for TCMD
Does Tactile Systems Technology (TCMD) Have the Potential to Rally 57.31% as Wall Street Analysts Expect?
Should Value Investors Buy Tactile Systems Technology (TCMD) Stock?
TCMD: What are Zacks experts saying now?
Zacks Private Portfolio Services
Tactile Systems Technology (TCMD) Recently Broke Out Above the 20-Day Moving Average
Tactile Systems Technology (TCMD) Crossed Above the 50-Day Moving Average: What That Means for Investors
Tactile Systems Technology (TCMD) Q2 Earnings and Revenues Surpass Estimates
Other News for TCMD
Tactile Systems Technology Breaks Above 200-Day Moving Average - Bullish for TCMD
Analysts Offer Insights on Healthcare Companies: Ginkgo Bioworks Holdings (DNA), BioMarin Pharmaceutical (BMRN) and Tactile Systems Technology (TCMD)
TCMD Makes Bullish Cross Above Critical Moving Average
Oppenheimer Remains a Buy on Tactile Systems Technology (TCMD)
Tactile Systems Technology (TCMD) Gets a Buy from Piper Sandler